Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions
Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions have?
Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions has 364 citations in the OpenAlex counts ScholarIQ stores.
When was Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions published?
Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions has 2023 year in the ScholarIQ index.
What is the open-access status of Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions?
Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions has closed oa status in the ScholarIQ index.
What is the DOI of Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions?
The DOI for Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions is on the source record.
What is the PMID of Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions?
The PMID for Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions is on the source record.
What is the OpenAlex record for Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions?
The OpenAlex for Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions is on the source record.